Si-bone, inc. announces first-in-patient procedures with fda breakthrough device for pelvic fracture fixation

Santa clara, calif., oct. 10, 2024 (globe newswire) -- si-bone, inc. (nasdaq: sibn), a silicon valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced first-in-patient procedures with the fda-designated breakthrough device, ifuse torq tnt™ implant system (tnt). designed to address the anatomic and biomechanical challenges of pelvic fragility fractures, particularly in patients with poor bone quality, tnt offers a significant advancement over traditional cannulated screws.
SIBN Ratings Summary
SIBN Quant Ranking